Certain A Shares of BMC Medical Co., Ltd. are subject to a Lock-Up Agreement Ending on 1-NOV-2023.
November 31, 2023
Share
Certain A Shares of BMC Medical Co., Ltd. are subject to a Lock-Up Agreement Ending on 1-NOV-2023. These A Shares will be under lockup for 376 days starting from 21-OCT-2022 to 1-NOV-2023.
Details:
The controlling shareholder and actual controller Zhuang Zhi and Xu Jian promised within 36 months since the date of listing of the present shares, there will not be no transfers nor entrustment of shares to any third party nor repurchase by the Company. If, within 6 months after the issuer's listing, the closing price of the shares is lower than issuance price for 20 consecutive trading days or if trading price is lower than issuance price after 6 month from listing, lock-up period will be automatically extended for another 6 months. After the expiry of the lock-up period (including the extended lock-up period), during the time serves as the company director, supervisor and senior manager, the party promise that yearly transfer of shares made by him/her will not exceed 25% of the holding.
Beijing Runmai Investment Development Center (Limited Partnership), Beijing Runyi Enterprise Management Development Center (Limited Partnership) promised within 36 months since the date of listing of the present shares, there will not be no transfers nor entrustment of shares to any third party nor repurchase by the Company. If, within 6 months after the issuer's listing, the closing price of the shares is lower than issuance price for 20 consecutive trading days or if trading price is lower than issuance price after 6 month from listing, lock-up period will be automatically extended for another 6 months.
Shareholder Chen Bei promised within 36 months since the date of listing of the present shares, there will not be no transfers nor entrustment of shares to any third party nor repurchase by the Company.
Shareholders and supervisors Su Lin and Xiao Aijun; Supervisor Xue Dongwei, senior executives Gao Chengwei, Qi Yuguang, and Zhang Xiaochao promised within 12 months from the date of listing of the company?s shares, I shall not transfer or entrust others to manage the shares that I directly or indirectly hold before the company?s initial public offering, nor shall the company repurchase those shares. After the expiry of the lock-up period (including the extended lock-up period), during the time serves as the company director, supervisor and senior manager, the party promise that yearly transfer of shares made by him/her will not exceed 25% of the holding.
Other shareholders promised within 12 months from the date of listing of the company?s shares, I shall not transfer or entrust others to manage the shares that I directly or indirectly hold before the company?s initial public offering, nor shall the company repurchase those shares.
BMC Medical Co Ltd is a China-based company mainly engaged in the manufacture of medical equipment and consumable products in the field of respiratory health. The Company's products mainly include non-invasive home ventilators, ventilation masks, sleep monitors and high-flow humidified oxygen therapy devices. The Company also provides respiratory health chronic disease management services. The Company focuses on the treatment of patients with sleep apnea-hypopnea syndrome (SAHS), mainly obstructive sleep apnea syndrome (OSA), as well as patients with respiratory insufficiency, mainly chronic obstructive pulmonary disease (COPD), providing a full-cycle and multi-scenario overall solution for treatment services.